UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000012658
Receipt No. R000014804
Official scientific title of the study Effects of age on recovery from neuromuscular blockade with and without sugammadex
Date of disclosure of the study information 2013/12/23
Last modified on 2017/06/01 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effects of age on recovery from neuromuscular blockade with and without sugammadex
Title of the study (Brief title) Recovery from neuromuscular block with sugammadex and aging
Region
Japan

Condition
Condition Patients undergoing general anesthesia
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To test an hypothesis that aging effects recovery from non-depolizing neuromuscular block with sugammadex.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Train of four ratio
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -but assessor(s) are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 aging
Interventions/Control_2 sugammadex administration
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Adult patients scheduled for surgeries undergoing general anesthesia
Key exclusion criteria Patients with ASA class greater than 3, allergies for rocuronium and/or propofol and sugammadex, and patients who is contraindicated for administration of neuromuscular blockade and sugammadex.
Target sample size 40

Research contact person
Name of lead principal investigator Shiroh Isono
Organization Graduate School of Medhicine, Chiba University
Division name Department of Anesthesiology
Address 1-8-1 Inohana, Chuo-ku, Chiba
TEL 043-226-2155
Email shirohisono@yahoo.co.jp

Public contact
Name of contact person Shiroh Isono
Organization Graduate School of Medhicine, Chiba University
Division name Department of Anesthesiology
Address 1-8-1 Inohana, Chuo-ku, Chiba
TEL 043-226-2155
Homepage URL
Email shirohisono@yahoo.co.jp

Sponsor
Institute Graduate School of Medicine, Chiba University, Department of Anesthesiology
Institute
Department

Funding Source
Organization Institutional
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2013 Year 12 Month 23 Day

Progress
Recruitment status Completed
Date of protocol fixation
2013 Year 12 Month 12 Day
Anticipated trial start date
2013 Year 12 Month 24 Day
Last follow-up date
2016 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
2016 Year 03 Month 31 Day
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2013 Year 12 Month 23 Day
Last modified on
2017 Year 06 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014804